Ambu recently announced new capabilities for its single-use aScope 4 RhinoLaryngo Slim and aView 2 Advance HD monitor.
The new capabilities bring Ambu single-use endoscopy to bear on fibreoptic endoscopic evaluation of swallowing (FEES) procedures, which Ambu officials take place more than 1 million times a year across key markets in North America, Europe and the Asia-Pacific region.